Outcomes of Patient Blood Management in Patients Undergoing Major Surgery

CompletedOBSERVATIONAL
Enrollment

25,979

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Major Surgery
Interventions
BIOLOGICAL

Allogeneic transfusion

Anemia is treated by administering donor red cells, and bleeding or coagulopathy by plasma, platelets or other donor blood products.

OTHER

Patient Blood Management

PBM is a strategy to manage the participants own blood. Its focus is on anemia, bleeding and coagulation management (using predominantly pharmaceutical and technological means).

Trial Locations (1)

99867

Helios Klinikum, Gotha

All Listed Sponsors
collaborator

HELIOS Hospital, Erfurt, Germany

OTHER

collaborator

Matthias Lucas

UNKNOWN

lead

Helios Klinik Gotha/Ohrdruf

OTHER

NCT06553833 - Outcomes of Patient Blood Management in Patients Undergoing Major Surgery | Biotech Hunter | Biotech Hunter